SLC2A1 and acute myeloid leukemia: Several studies have demonstrated that increased HIF1A expression in AML is associated with upregulation of genes such as VEGF, GLUT1, and heme oxygenase-1 (HO-1); encouraging disease progression through increased angiogenic, metabolic, and apoptotic processes, respectively [164–167].